Efficacy and safety of tocilizumab in hospitalized COVID-19 patients: A systematic review and meta-analysis

J Infect. 2022 Mar;84(3):418-467. doi: 10.1016/j.jinf.2021.11.013. Epub 2021 Nov 20.
No abstract available

Publication types

  • Letter
  • Meta-Analysis
  • Research Support, Non-U.S. Gov't
  • Systematic Review

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects
  • COVID-19 Drug Treatment*
  • Humans
  • SARS-CoV-2

Substances

  • Antibodies, Monoclonal, Humanized
  • tocilizumab